Sun Pharma, Lupin, 2 others invest in ABCD Technologies
New Delhi: Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies LLP which will be renamed as IndoHealth Services LLP.
The four pharma majors are investing Rs 40 crore each in the target entity which is a recently incorporated limited liability partnership and has not commenced any business activities, they added.
Sun Pharma and Cadila Healthcare said one of the wholly owned Indian subsidiaries have subscribed to partnership interest in ABCD Technologies LLP.
The objective of the acquisition is to facilitate, enable and promote efficiency and good distribution practices, including digitising healthcare infrastructure in India, inter alia, in support of the National Digital Health Mission of Government of India, the regulatory filings said.
The nature of consideration is cash infusion as capital contribution and Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma are investing Rs 40 crore each in the target entity, they added.
While Sun Pharma and Cadila Healthcare said that Rs 40 crore is for 20 per cent share of profit/ loss in the target entity, Lupin and Torrent Pharma said Rs 40 crore is for up to 20 per cent share of profit/loss in the target entity.
Read also: Sun Pharma, Dr Reddys, others eyeing to buy Oaknet Healthcare: Report
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.